Frankfurt
15.07.26 | 08:02
0,053 Euro
0,00 % 0,000
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,053 | 0,072 | 09:56 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 26.06. | Ventripoint Diagnostics Ltd (2): Ventripoint enters collaboration with Ollie Hinkle | 1 | Stockwatch | ||
| 26.06. | Stocks in Play: Ventripoint Diagnostics Ltd | - | Baystreet.ca | ||
| 26.06. | Ventripoint Diagnostics Ltd.: Ventripoint and Ollie Hinkle Heart Foundation Partner to Expand Access to AI-Powered Heart Imaging for Children Living with Heart Disease | 1 | TheNewswire | ||
| 15.06. | Ventripoint Diagnostics Ltd (2): Ventripoint joins congenital heart disease alliance | 3 | Stockwatch | ||
| 15.06. | Stocks in Play: Ventripoint Diagnostics Ltd | 1 | Baystreet.ca | ||
| VENTRIPOINT DIAGNOSTICS Aktie jetzt für 0€ handeln | |||||
| 15.06. | Ventripoint Diagnostics Ltd.: Ventripoint Diagnostics Announces Support for the Global Congenital Heart Disease Alliance | 1 | TheNewswire | ||
| 30.05. | Ventripoint Diagnostics Ltd.: Ventripoint Announces Adoption of Semi-Annual Reporting (SAR) | 2 | TheNewswire | ||
| 25.05. | Stocks in Play: Ventripoint Diagnostics Ltd | 1 | Baystreet.ca | ||
| 25.05. | Ventripoint Diagnostics Ltd.: Ventripoint Provides Videoconference Link to Annual General Meeting and Corporate Update | 4 | TheNewswire | ||
| 22.05. | Ventripoint Diagnostics Ltd (2): Ventripoint Diagnostics closes $308,030 financing | 1 | Stockwatch | ||
| 22.05. | Ventripoint Diagnostics Ltd.: Ventripoint Announces Closing of $308,030 Non-Brokered Units Private Placement | 1 | TheNewswire | ||
| 20.05. | Ventripoint Diagnostics Ltd (2): Ventripoint issues shares for interest of $61,217 | 1 | Stockwatch | ||
| 19.05. | Ventripoint Diagnostics Ltd.: Ventripoint Issues Shares for Payment of Debenture Interest | 1 | TheNewswire | ||
| 15.05. | Ventripoint Diagnostics Ltd (2): Ventripoint Diagnostics 555,699 shares for debt | 1 | Stockwatch | ||
| 04.05. | Ventripoint Diagnostics Ltd.: Ventripoint to Exhibit at the 59th Annual Meeting of the Association for European Paediatric and Congenital Cardiology | 1 | TheNewswire | ||
| 29.04. | Ventripoint Diagnostics Ltd (2): Ventripoint's VMS+ 4.0 submitted for approval in China | 1 | Stockwatch | ||
| 28.04. | Stocks in Play: Ventripoint Diagnostics Ltd | 1 | Baystreet.ca | ||
| 28.04. | Ventripoint Diagnostics Ltd.: Ventripoint's VMS+ 4.0 Submitted for Regulatory Approval in China by Lishman Global Inc. | 2 | TheNewswire | ||
| 23.04. | Ventripoint Diagnostics Ltd (2): Ventripoint to issue 555,699 shares as interest payment | 1 | Stockwatch | ||
| 22.04. | Ventripoint Diagnostics Ltd.: Ventripoint Issue Shares for Payment of Debenture Interest | 2 | TheNewswire |
1 2 3 Weiter >>
49 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ATOSSA THERAPEUTICS | 2,040 | +3,55 % | Atossa Therapeutics Inc: Atossa Therapeutics Announces Closing of Registered Direct Offering of up to $16.5 Million in Gross Proceeds | $4.5 million upfront with up to an additional $12 million of potential aggregate gross proceeds upon exercise in full of warrants
SEATTLE, June 12, 2026 /PRNewswire/... ► Artikel lesen | |
| TANDEM DIABETES | 13,700 | +0,74 % | Tandem Diabetes Care, Inc.: Tandem Diabetes Care Launches t:slim X2 Insulin Pump Compatibility with Abbott FreeStyle Libre 3 Plus Sensor in Five International Markets | Compatibility now available in five countries, with additional markets expected throughout 2026.Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company... ► Artikel lesen | |
| MOLINA HEALTHCARE | 209,50 | -0,95 % | TD Cowen raises Molina Healthcare stock price target on utilization outlook | ||
| VERU | 2,300 | -0,43 % | Top Biotech Gainers: VERU Teams Up With NVO, ABSI On Watch, ALVO Resubmits BLAs To FDA... | REYKJAVIK (dpa-AFX) - Thursday's top gainers include Veru, following a Novo Nordisk collaboration; Health Catalyst, following a divestment of its revenue workflow and analytics software business... ► Artikel lesen | |
| CLOVER HEALTH INVESTMENTS | 4,260 | +0,95 % | Clover Health Investments, Corp.: Clover Health to Report Second Quarter 2026 Financial Results on August 5, 2026 | ||
| SOMNIGROUP INTERNATIONAL | 62,52 | -1,17 % | SOMNIGROUP INTERNATIONAL INC. - S-4/A, Registration of securities, business combinations | ||
| SINTX TECHNOLOGIES | 1,570 | +0,64 % | SINTX Technologies, Inc.: SINTX Technologies Announces Receipt of More Than $3.2 Million in Contract Manufacturing Purchase Orders | SALT LAKE CITY, Utah, June 22, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) ("SINTX" or the "Company"), a leader in advanced silicon nitride ceramics and advanced material technologies... ► Artikel lesen | |
| NEURONETICS | 1,515 | -2,57 % | Neuronetics Appoints Robert Greene as Senior Vice President Sales | MALVERN, Pa., June 02, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 69,68 | +0,01 % | Raymond James initiates BrightSpring Health stock with outperform rating | ||
| BILLIONTOONE | 124,59 | -0,22 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 21,210 | +0,05 % | Kaplan Fox & Kilsheimer LLP: Kaplan Fox Alerts Investors of Alignment Healthcare, Inc. (ALHC) to an Investigation of Potential Securities Law Violations | New York, New York--(Newsfile Corp. - July 10, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. ("Alignment Healthcare" or... ► Artikel lesen | |
| BETA BIONICS | 16,860 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Announces First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | IRVINE, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| GENEDX | 62,37 | -0,10 % | Piper Sandler raises GeneDx stock price target on coverage policy | ||
| HEARTFLOW | 25,500 | +0,04 % | Heartflow, Inc.: New Data at SCCT 2026 Reinforce Heartflow Plaque Analysis as the Standard for AI-Powered Coronary Artery Disease Management | ||
| ADAPTHEALTH | 10,190 | 0,00 % | AdaptHealth Flags Material Breach After Threat Actor Accessed Patient Management Systems |
VENTRIPOINT DIAGNOSTICS LTD gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,053 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VENTRIPOINT DIAGNOSTICS LTD finden Sie auf Wallstreet Online.